Characteristic | SLE | JIA | |
---|---|---|---|
n = 21 | n = 26 | ||
Age (years, average ± SD) | 15.1 ± 2.6 | 11.7 ± 5.0 | |
Gender | |||
Female | 19 (90.5%) | 17 (65.4%) | |
Male | 2 (9.5%) | 9 (34.6%) | |
Race | |||
Asian | 2 (9.5%) | 4 (15.4%) | |
Black or African American | 8 (38.1%) | 5 (19.2%) | |
White | 3 (14.3%) | 6 (23.1%) | |
Unknown/Not Reported | 8 (38.1%) | 11 (42.3%) | |
Ethnicity | |||
Hispanic or Latino | 14 (66.7%) | 17 (65.4%) | |
Not Hispanic or Latino | 6 (28.6%) | 8 (30.8%) | |
Unknown/Not Reported | 1 (4.8%) | 1 (3.8%) | |
Insurance | |||
Private | 2 (9.5%) | 6 (23.1%) | |
Medicaid | 18 (85.7%) | 20 (76.9%) | |
Other | 1 (4.8%) | 0 (0%) | |
Disease Duration | |||
0–6 months | 8 (38.1%) | 8 (30.8%) | |
6–12 months | 2 (9.5%) | 8 (30.8%) | |
12–18 months | 0 (0%) | 2 (7.7%) | |
18–24 months | 2 (9.5%) | 1 (3.8%) | |
2–3 years | 3 (14.3%) | 4 (15.4%) | |
> 3 years | 6 (28.6%) | 3 (11.5%) | |
JIA Subtype | |||
Oligoarticular | 3 (11.5%) | ||
Polyarticular | 10 (38.5%) | ||
Psoriatic arthritis | 2 (7.7%) | ||
Enthesitis-related arthritis | 4 (15.4%) | ||
Systemic | 5 (19.2%) | ||
Undifferentiated | 2 (7.7%) | ||
CD-RISC Score (average ± SD) | 24.4 ± 9.1 | 25.2 ± 7.2 | |
SLEDAI score (average ± SD) | 8.10 ± 7.67 | ||
JADAS score (average ± SD) | 8.03 ± 9.43 |